Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix

Sidney S. Chen, David Koffler, Carmel J. Cohen

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

A group of patients with squamous cell carcinoma of the cervix were tested for cellular hypersensitivity prior to the initiation of therapy. Fourteen of 15 patients manifested inhibition of leukocyte migration with homologous tumor extracts, and 13 patients showed inhibition with autologous tumor extracts. Lymphocytes from 10 of 11 patients exhibited cytotoxicity for a homologous cell line and lymphocytes from 4 of 5 patients, for autologous cell lines. These results indicate that the absence of cellular hypersensitivity is infrequent in patients with squamous cell carcinoma. A comparison of the degree of sensitivity detected by use of each test showed a good correlation in a group of 10 patients. The efficacy of both autologous and homologus antigens to react with sensitized leukocytes supports the hypothesis that these antigens are tumor related. Although no correlation was found among the immunologic tests, clinical status of the patient, or prognosis based on the evaluation of several histologic parameters, further studies are needed to determine the usefulness of these tests as a prognostic index in individual patients, especially in patients with Stage I carcinoma.

Original languageEnglish
Pages (from-to)91-95
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume121
Issue number1
DOIs
StatePublished - 1 Jan 1975

Fingerprint

Dive into the research topics of 'Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix'. Together they form a unique fingerprint.

Cite this